Holen Sie sich die Stockscreener-App
1.21
14.18%
-0.20
Glucotrack Inc Aktie (GCTK) Neueste Nachrichten
Lokahi announces health platform to compare GLP-1 outcomes - Investing.com
Lokahi announces health platform to compare GLP-1 outcomes By Investing.com - Investing.com Canada
Patients may soon compare medication experiences with others like them. - Stock Titan
Form 8K GlucoTrack Inc For: 28 September By Investing.com - Investing.com Nigeria
Glucotrack announces amendments to warrant and note agreements, repays bridge notes - Investing.com
Glucotrack announces pricing of public offering - Medical Buyer
Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™ - The National Law Review
Emerging Growth DRK GLND APUS GCTK Stocks in the News - marketscreener.com
Form 424B5 GlucoTrack Inc For: 24 September By Investing.com - Investing.com Canada
GlucoTrack Announces Debt-Reducing Public Equity Offering - TipRanks
Glucotrack Prices $3.1 Million Registered Direct Offering of Stock and Pre-Funded Warrants - TradingView
GlucoTrack Shares More Than Double After Subsidiary Lands First Fee-for-Service Deal - finance.biggo.com
What's Going On With GlucoTrack Shares On Thursday? - Benzinga
Medical device developer Glucotrack Inc. announces pricing of $3M public offering - ROI-NJ
GlucoTrack Jumps as New Platform Commercialization News Appears to Outweigh Fresh Offering - Moomoo
Glucotrack prices $3.1 million public offering at $2.04/share - Investing.com India
GCTK Stock Slides As Lokahi Platform And LT-100 Gain Steam - StocksToTrade
GCTK Stock Draws Traders As Lokahi Strategy Takes Shape - timothysykes.com
Lokahi Therapeutics and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai-2 Platform Growth and Clinical Development Priorities - marketscreener.com
GlucoTrack, Inc. Announces Pricing of $3 Mill - Moomoo
GCTK Stock Draws Traders As Lokahi Pipeline And ai² Platform Advance - timothysykes.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
GCTK Stock Draws Traders As Lokahi Pivot Accelerates - StocksToTrade
GCTK Stock Draws Traders As Lokahi Platform And LT-100 Advance - timothysykes.com
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket - Benzinga
GlucoTrack Stock Surges 80% After Hours on Brain Tumor DealGlucoTrack (NASDAQ:GCTK) - Benzinga
Lōkahi Therapeutics™ and GlucoTrack CEO Erik - Moomoo
Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform - 01net
Trending Stocks Today | Glucotrack Shoots up 92.61% Post-Market - Moomoo
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Form 4 GlucoTrack Inc For: 23 September By Investing.com - Investing.com Canada
Form 8K GlucoTrack Inc For: 23 September - Investing.com India
Form 8K GlucoTrack Inc For: 23 September By Investing.com - Investing.com Canada
GlucoTrack and Lōkahi Outline Post-Merger Strategic Focus - TipRanks
Form 4 GlucoTrack Inc For: 23 September - Investing.com India
Shelved drug trove powers Glucotrack (NASDAQ: GCTK) ai² search for new therapies - Stock Titan
Glucotrack issues strategic update: LT-100 clinical study targeted, ai² platform expands university network - TradingView
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities - Business Wire
GlucoTrack Director Resigns Amid Merger Conflict Concerns - The Globe and Mail
Form 8K GlucoTrack Inc For: 18 September By Investing.com - Investing.com Nigeria
Glucotrack director Paul V. Goode resigns citing potential conflict of interest - Investing.com
Board member quits Glucotrack (GCTK) over merger conflict - Stock Titan
Glucotrack, Inc. Announces Resignation of Paul V. Goode from the Board of Directors, Effective September 14, 2026 - marketscreener.com
Alabama students identified more than 45 potential treatments - Stock Titan
Glucotrack (NASDAQ: GCTK) registers shares equal to 5,442% of stock outstanding - Stock Titan
Glucotrack shareholders approve stock issuance proposals and amend warrant terms By Investing.com - Investing.com South Africa
Form 8K GlucoTrack Inc For: 14 September By Investing.com - Investing.com Canada
Glucotrack shareholders approve stock issuance proposals and amend warrant terms - Investing.com
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Australia
Why Is GlucoTrack (GCTK) in Focus? - kalkinemedia.com
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
Glucotrack Prices $11.5 Million Convertible Note Financing - minichart.com.sg
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Australia
2.06%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):